Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

If Successful, HRA Pharma Acquisition Will Complete Perrigo’s Pivot Towards Self-Care

Dec 21 2021

• By David Ridley

strategy concept - hands holding back-lit blue puzzle pieces coming together — • Source: Shutterstock

Related Content

Perrigo Takes $50M Step For US Consumer Health Industry Into CBD, Invests In Supplier Kazmira

Jun 17 2020

Perrigo Exploring The CBD Opportunity

Jan 30 2020

HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives

Jul 09 2021

Perrigo Feels Chill From Q3 Results Due To ‘Unfulfilled’ Demand On Supply Chain Disruptions

Nov 10 2021

Bayer Crowned Company Of The Year At OTC Marketing Awards 2021

Dec 02 2021

Half Of All OTCs Could Disappear From Northern Ireland Under Current Brexit Rules

Nov 01 2021

Ranir Oral Care Deal Could Brighten Perrigo's Turnaround Chances

May 13 2019

Perrigo Strengthens In Europe With Sanofi Skin-Care Brands

Aug 12 2020

Additional Topics

International Business Strategies Brexit Cannabidiol CBD Companies Consumer Coronavirus COVID-19 Dietary Supplements Deals M & A OTC Drugs Strategy Supply Chain

More from International

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.